World Of Taxonomy
0069-1500Level 3

Xalkori (CRIZOTINIB)

**Product type:** Human Prescription Drug

**Active ingredient:** CRIZOTINIB

**Strength:** 150 mg/1

**Dosage form:** Capsule, Coated Pellets

**Route:** Oral

**Labeler:** Pfizer Laboratories Div Pfizer Inc

**Marketing category:** NDA (NDA217581)

**Pharmacologic class:** Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/0069-1500
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.